New molecular targets for antiepileptic drugs: α2δ, SV2A, and Kv7/KCNQ/M potassium channels

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Current Neurology and Neuroscience Reports

• Publication date

  2008-10-16

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/S11910-008-0053-7
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacological disruption of calcium channel trafficking by the α2δ ligand gabapentin

  2008cited by this paper
• N-(6-Chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): A Novel, Selective KCNQ2/Q3 Potassium Channel Activator

  2008cited by this paper
• Nervous system KV7 disorders: breakdown of a subthreshold brake

  2008cited by this paper
• Early treatment suppresses the development of spike‐wave epilepsy in a rat model

  2008cited by this paper
• Timed pentylenetetrazol infusion test: a comparative analysis with s.c.PTZ and MES models of anticonvulsant screening in mice.

  2007cited by this paper
• Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures

  2007cited by this paper
• M-Channels (Kv7/KCNQ Channels) That Regulate Synaptic Integration, Excitability, and Spike Pattern of CA1 Pyramidal Cells Are Located in the Perisomatic Region

  2007cited by this paper
• Pre- and postsynaptic activation of M-channels by a novel opener dampens neuronal firing and transmitter release.

  2007cited by this paper
• Ca2+ channel α2δ ligands: novel modulators of neurotransmission

  2007cited by this paper
• The chemical synapse goes electric: Ca2+- and voltage-sensitive GPCRs control neurotransmitter release.

  2007cited by this paper
• Functional biology of the α 2 δ subunits of voltage-gated calcium channels

  2007cited by this paper
• Nodes of Ranvier and axon initial segments are ankyrin G–dependent domains that assemble by distinct mechanisms

  2007cited by this paper
• Immunohistochemical analysis of KCNQ2 potassium channels in adult and developing mouse brain.

  2006cited by this paper
• A Common Ankyrin-G-Based Mechanism Retains KCNQ and NaV Channels at Electrically Active Domains of the Axon

  2006cited by this paper
• SV2 Is the Protein Receptor for Botulinum Neurotoxin A

  2006cited by this paper
• Pregabalin Reduces the Release of Synaptic Vesicles from Cultured Hippocampal Neurons

  2006cited by this paper
• Axo-somatic and apical dendritic Kv7/M channels differentially regulate the intrinsic excitability of adult rat CA1 pyramidal cells.

  2006cited by this paper
• KCNQ/Kv7 channel regulation of hippocampal gamma-frequency firing in the absence of synaptic transmission.

  2006cited by this paper
• Molecular targets versus models for new antiepileptic drug discovery.

  2006cited by this paper
• A Spontaneous Mutation Involving Kcnq2 (Kv7.2) Reduces M-Current Density and Spike Frequency Adaptation in Mouse CA1 Neurons

  2006cited by this paper
• Somatodendritic Kv7/KCNQ/M Channels Control Interspike Interval in Hippocampal Interneurons

  2006cited by this paper
• Synaptic Vesicle Protein 2 Enhances Release Probability at Quiescent Synapses

  2006cited by this paper
• Kv7/KCNQ/M‐channels in rat glutamatergic hippocampal axons and their role in regulation of excitability and transmitter release

  2006cited by this paper
• Calcium channel alpha2-delta type 1 subunit is the major binding protein for pregabalin in neocortex, hippocampus, amygdala, and spinal cord: an ex vivo autoradiographic study in alpha2-delta type 1 genetically modified mice.

  2006cited by this paper
• Immunohistochemical analysis of KCNQ3 potassium channels in mouse brain.

  2006cited by this paper
• KCNQ channels mediate IKs, a slow K+ current regulating excitability in the rat node of Ranvier

  2006cited by this paper
• K(v)7 channels: function, pharmacology and channel modulators.

  2006cited by this paper
• Identification of the (cid:1) 2 - (cid:2) -1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin

  2006cited by this paper
• Kv7/KCNQ/M and HCN/h, but not KCa2/SK channels, contribute to the somatic medium after‐hyperpolarization and excitability control in CA1 hippocampal pyramidal cells

  2005cited by this paper
• International Union of Pharmacology. LII. Nomenclature and Molecular Relationships of Calcium-Activated Potassium Channels

  2005cited by this paper
• RETIGABINE :B ENDING POTASSIUM CHANNELS TO OUR WILL The New Anticonvulsant Retigabine Favors Voltage-dependent Opening of the Kv7.2 (KCNQ2) Channel by Binding to Its Activation Gate

  2005cited by this paper
• Molecular Determinants of KCNQ (Kv7) K+ Channel Sensitivity to the Anticonvulsant Retigabine

  2005cited by this paper
• Pathways modulating neural KCNQ/M (Kv7) potassium channels

  2005cited by this paper
• Structure−Activity Relationships of Pregabalin and Analogues That Target the α2-δ Protein

  2005cited by this paper
• Cerebellar ataxia, seizures, premature death, and cardiac abnormalities in mice with targeted disruption of the Cacna2d2 gene.

  2004cited by this paper
• M Channels Containing KCNQ2 Subunits Modulate Norepinephrine, Aspartate, and GABA Release from Hippocampal Nerve Terminals

  2004cited by this paper
• Mice Carrying the Szt1 Mutation Exhibit Increased Seizure Susceptibility and Altered Sensitivity to Compounds Acting at the M‐Channel

  2004cited by this paper
• KCNQ/M Channels Control Spike Afterdepolarization and Burst Generation in Hippocampal Neurons

  2004cited by this paper
• entla, a Novel Epileptic and Ataxic Cacna2d2 Mutant of the Mouse*

  2004cited by this paper
• The neurobiology of antiepileptic drugs

  2004cited by this paper
• Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity.

  2004cited by this paper
• Dual effects of gabapentin and pregabalin on glutamate release at rat entorhinal synapses in vitro

  2004cited by this paper
• KCNQ2 Is a Nodal K+ Channel

  2004cited by this paper
• Effect of the KCNQ potassium channel opener retigabine on single KCNQ2/3 channels expressed in CHO cells

  2003cited by this paper
• Localization and photoaffinity labelling of the levetiracetam binding site in rat brain and certain cell lines.

  2003cited by this paper
• International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

  2003cited by this paper
• Effects of the anticonvulsant retigabine on cultured cortical neurons: changes in electroresponsive properties and synaptic transmission.

  2002cited by this paper
• Gabapentin inhibits presynaptic Ca(2+) influx and synaptic transmission in rat hippocampus and neocortex.

  2002cited by this paper
• Molecular cloning and characterization of the human voltage-gated calcium channel alpha(2)delta-4 subunit.

  2002cited by this paper
• Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex.

  2002cited by this paper
• Molecular correlates of the M‐current in cultured rat hippocampal neurons

  2002cited by this paper
• Antibodies and a cysteine‐modifying reagent show correspondence of M current in neurons to KCNQ2 and KCNQ3 K+ channels

  2002cited by this paper
• Activation of Expressed KCNQ Potassium Currents and Native Neuronal M-Type Potassium Currents by the Anti-Convulsant Drug Retigabine

  2001cited by this paper
• KCNQ potassium channels: physiology, pathophysiology, and pharmacology.

  2001cited by this paper
• Calcium Channel α2δ Subunits—Structure and Gabapentin Binding

  2001cited by this paper
• Ducky Mouse Phenotype of Epilepsy and Ataxia Is Associated with Mutations in the Cacna2d2 Gene and Decreased Calcium Channel Current in Cerebellar Purkinje Cells

  2001cited by this paper
• KCNQ5, a Novel Potassium Channel Broadly Expressed in Brain, Mediates M-type Currents*

  2000cited by this paper
• The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunits.

  2000cited by this paper
• Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels.

  2000cited by this paper
• Anticonvulsant efficacy of gabapentin and levetiracetam in phenytoin-resistant kindled rats.

  2000cited by this paper
• Colocalization and coassembly of two human brain M-type potassium channel subunits that are mutated in epilepsy.

  2000cited by this paper
• Inhibition of K(+)-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin.

  2000cited by this paper
• Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine.

  2000cited by this paper
• Molecular Cloning and Functional Expression of KCNQ5, a Potassium Channel Subunit That May Contribute to Neuronal M-current Diversity*

  2000cited by this paper
• KCNQ2/KCNQ3 K+ channels and the molecular pathogenesis of epilepsy: implications for therapy.

  2000cited by this paper
• Disruption of the Epilepsy KCNQ2 Gene Results in Neural Hyperexcitability

  2000cited by this paper
• Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A).

  1999cited by this paper
• Structural requirement of the calcium-channel subunit alpha2delta for gabapentin binding.

  1999cited by this paper
• 3‐Substituted GABA analogs with central nervous system activity: A review

  1999cited by this paper
• SV2: SVeeping up excess Ca2+ or tranSVorming presynaptic Ca2+ sensors?

  1999cited by this paper
• Structural requirement of the calcium-channel subunit α2δ for gabapentin binding

  1999cited by this paper
• Cloning and Deletion Mutagenesis of the α2δ Calcium Channel Subunit from Porcine Cerebral Cortex EXPRESSION OF A SOLUBLE FORM OF THE PROTEIN THAT RETAINS [3H]GABAPENTIN BINDING ACTIVITY

  1998cited by this paper
• KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel.

  1998cited by this paper
• Identification of Novel Ligands for the Gabapentin Binding Site on the α2δ Subunit of a Calcium Channel and Their Evaluation as Anticonvulsant Agents

  1998cited by this paper
• The new anticonvulsant retigabine (D-23129) acts as an opener of K+ channels in neuronal cells.

  1997cited by this paper
• Comparison of the preclinical anticonvulsant profiles of tiagabine, lamotrigine, gabapentin and vigabatrin.

  1997cited by this paper
• Axonal Action-Potential Initiation and Na+ Channel Densities in the Soma and Axon Initial Segment of Subicular Pyramidal Neurons

  1996cited by this paper
• The Novel Anticonvulsant Drug, Gabapentin (Neurontin), Binds to the Subunit of a Calcium Channel (*)

  1996cited by this paper
• Reduction of spike frequency adaptation and blockade of M‐current in rat CA1 pyramidal neurones by linopirdine (DuP 996), a neurotransmitter release enhancer

  1995cited by this paper
• The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes.

  1995cited by this paper
• Characterisation of [3H]gabapentin binding to a novel site in rat brain: homogenate binding studies.

  1993cited by this paper
• Brain contains two forms of synaptic vesicle protein 2.

  1993cited by this paper
• Presynaptic cholinergic actions by the putative cognitive enhancing agent DuP 996.

  1993cited by this paper
• Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds.

  1990cited by this paper
• Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone

  1980cited by this paper

• Synthesis and Pd(0)‐Catalyzed Arylation of Naphthalen‐2‐yl 5‐Bromofuran‐2‐Carboxylate Derivatives: Anticonvulsant Evaluation via In Vivo and In Silico Studies

  2026cites this paper
• Antiseizure Medications: Advancements, Challenges, and Prospects in Drug Development

  2025cites this paper
• Anhaltender CK-Anstieg nach epileptischem Anfall: auf der Suche nach der Ursache

  2025cites this paper
• Presynaptic antiseizure medications - basic mechanisms and clues for their rational combinations

  2024cites this paper
• Assessment of community pharmacists’ experiences and perceptions on gabapentin abuse in Jordan: a cross-sectional study

  2024cites this paper
• Validated spectrophotometric approach for the estimation of an antiepileptic drug: retigabine in pure form and pharmaceutical formulations utilizing N-Bromosuccinimide as an oxidant

  2024cites this paper
• XEN1101, a novel potassium channel opener: hope or hype for adults with focal seizure

  2024cites this paper
• Twenty-first century antiepileptic drugs. An overview of their targets and synthetic approaches.

  2024cites this paper
• The Effect of Oral Gabapentin and Pregabalin as a Prodrug in Pain Control after Orthopedic Surgery on the Upper Limb: A Double-Blind Parallel Randomized Clinical Trial Study

  2024cites this paper
• Modulation of Kv7 Channel Currents by Echinocystic Acid

  2023cites this paper
• Economic kilogram-scale synthesis of the novel antiepileptic drug brivaracetam utilizing porcine pancreatic lipase

  2023cites this paper
• Pregabalin can interact synergistically with Kv7 channel openers to exert antinociception in mice.

  2023cites this paper
• PHARMACOLOGICAL EVALUATION OF LEVETIRACETAM AS ADD-ON DRUG TO EITHER PHENYTOIN OR SODIUM VALPROATE IN PATIENTS OF GENERALIZED ONSET TONIC-CLONIC SEIZURES HAVING BREAKTHROUGH SEIZURES: A RANDOMIZED AND COMPARATIVE STUDY

  2023cites this paper
• Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy

  2023cites this paper
• A Brief Review of Analytical Methods for the Estimation of Brivaracetam in Pharmaceutical Formulation and Biological Matrices

  2022cites this paper
• Feasibility of gabapentin as an intervention for neurorecovery after an acute spinal cord injury: Protocol

  2022cites this paper
• Posttranslational modifications & lithium's therapeutic effect - potential biomarkers for clinical responses in psychiatric & neurodegenerative disorders.

  2021cites this paper
• Interactions among Lacosamide and Second-Generation Antiepileptic Drugs in the Tonic-Clonic Seizure Model in Mice

  2021cites this paper
• Continuous Seizure Emergency Evoked in Mice with Pharmacological, Electrographic, and Pathological Features Distinct from Status Epilepticus

  2021cites this paper
• The Integrated Effects of Brivaracetam, a Selective Analog of Levetiracetam, on Ionic Currents and Neuronal Excitability

  2021cites this paper
• Histological Assessment of the Effect of Lacosamide on the Kidney Tissue of Pregnant Albino Rats

  2020cites this paper
• OBSOLETE: The Auditory System Function - An Integrative Perspective

  2020cites this paper
• Identification, isolation, structural characterisation, synthesis and in silico toxicity prediction of the alkaline hydrolytic degradation product of brivaracetam by using LC-PDA, preparative HPLC, LC/HESI/LTQ, FTIR, and 1H NMR.

  2020cites this paper
• Polygonogram and isobolographic analysis of interactions between various novel antiepileptic drugs in the 6-Hz corneal stimulation-induced seizure model in mice

  2020cites this paper
• Current Evidence on Abuse and Misuse of Gabapentinoids

  2020cites this paper
• Brivaracetam for the treatment of focal-onset seizures: pharmacokinetic and pharmacodynamic evaluations

  2020cites this paper
• Polygonogram with isobolographic synergy for three-drug combinations of phenobarbital with second-generation antiepileptic drugs in the tonic–clonic seizure model in mice

  2020cites this paper
• Structural Basis for the Modulation of Human KCNQ4 by Small-Molecule Drugs.

  2020cites this paper
• The Pharmacotherapy of Impulsive Aggression in Psychopathic Disorders

  2020cites this paper
• Pharmacology of Calcium Channel

  2020cites this paper
• Dronedarone (a multichannel blocker) enhances the anticonvulsant potency of lamotrigine, but not that of lacosamide, pregabalin and topiramate in the tonic-clonic seizure model in mice.

  2019cites this paper
• Metabolomic analyses of vigabatrin (VGB)‐treated mice: GABA‐transaminase inhibition significantly alters amino acid profiles in murine neural and non‐neural tissues

  2019cites this paper
• Heightened misuse risk and addictive potential of gabapentinoids: the fate of effective anxiolytics

  2019cites this paper
• Combination of phenobarbital with phenytoin and pregabalin produces synergy in the mouse tonic-clonic seizure model: An isobolographic analysis.

  2018cites this paper
• Superparamagnetic Fe3 O4 Nanoparticles in a Deep Eutectic Solvent: An Efficient and Recyclable Catalytic System for the Synthesis of Primary Carbamates and Monosubstituted Ureas

  2018cites this paper
• How addictive are gabapentin and pregabalin? A systematic review.

  2017cites this paper
• Levetiracetam synergizes with gabapentin, pregabalin, duloxetine and selected antioxidants in a mouse diabetic painful neuropathy model

  2017cites this paper
• The role of glutamate and GABA receptors in the anticonvulsive effects of levetiracetam and a 4-phenylpirrolidone derivative (GIZh-290) in rats

  2017cites this paper
• Basic Mechanisms of Action of the Antiepileptic Drugs

  2017cites this paper
• Design, Synthesis, and Docking Study of Pyrimidine–Triazine Hybrids for GABA Estimation in Animal Epilepsy Models

  2017cites this paper
• Evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein

  2017cites this paper
• Early Gabapentin Treatment during the Latency Period Increases Convulsive Threshold, Reduces Microglial Activation and Macrophage Infiltration in the Lithium-Pilocarpine Model of Epilepsy

  2017cites this paper
• 63 – Neurophysiology of Seizures and Epilepsy

  2017cites this paper
• Use of Animal Models for Epilepsy Research and Therapy Development

  2017cites this paper
• Synthesis of chiral lactams via asymmetric hydrogenation of α,β-unsaturated nitriles.

  2016cites this paper
• Highly efficient asymmetric hydrogenation of cyano-substituted acrylate esters for synthesis of chiral γ-lactams and amino acids.

  2016cites this paper
• Do traditional anti-seizure drugs have a future? A review of potential anti-seizure drugs in clinical development.

  2016cites this paper
• Critical analysis of carcinogenicity study outcomes. Relationship with pharmacological properties

  2016cites this paper
• Emerging drugs for partial-onset epilepsy: a review of brivaracetam

  2016cites this paper
• Review article Newer antiepileptic drugs

  2015cites this paper
• Newer antiepileptic drugs

  2015cites this paper
• The dilemma of treatments for epileptic patients with depression

  2015cites this paper
• Mechanisms of action of antiepileptic drugs

  2015cites this paper
• Novel Molecular Targets for Drug-Treatment of Epilepsy

  2015cites this paper
• Development and validation of a quantitative method for determination of retigabine and its N-acetyl metabolite; overcoming challenges associated with circulating labile N-glucuronide metabolites

  2015cites this paper
• Determination of 5-(3-Chlorophenyl)-4-hexyl-2,4-dihydro-3H-1,2,4-triazole-3-thione in Mouse Brain Tissue by Microwave-Assisted Extraction and High-Performance Liquid Chromatography with Fluorescence Detection

  2015cites this paper
• Development and validation of gradient stability indicating HPLC method for determining Ezogabine and related substances

  2015cites this paper
• Development and validation of analytical methods for related substances from active pharmaceutical ingredient using HPLC technique

  2015cites this paper
• An improved RP-HPLC method for the quantitative determination and validation of Retigabine in bulk and Pharmaceutical formulation

  2015cites this paper
• Seizures and epilepsy: an overview for neuroscientists.

  2015cites this paper
• The effects of preoperative oral pregabalin and perioperative intravenous lidocaine infusion on postoperative morphine requirement in patients undergoing laparatomy

  2015cites this paper
• Pharmacoresistant Epilepsy: A Current Update on Non-Conventional Pharmacological and Non-Pharmacological Interventions

  2015cites this paper
• 1,2,4-triazole derivatives as potential scaffold for anticonvulsant activity.

  2015cites this paper
• Design, synthesis, docking, and biological evaluation of some novel 5-chloro-2-substituted sulfanylbenzoxazole derivatives as anticonvulsant agents

  2014cites this paper
• Future Trends in Neuronal Networks—Selective and Combined Targeting of Network Hubs

  2014cites this paper
• Neuronal Network Effects of Drug Therapies for CNS Disorders

  2014cites this paper
• Current Issues in Pharmacy and Medical Sciences

  2014cites this paper
• Isolation, identification and structure elucidation of two novel process-related impurities of retigabine.

  2014cites this paper
• What are the arguments for and against rational therapy for epilepsy?

  2014cites this paper
• SYNTHESIS AND BIOLOGICAL SCREENING OF DIHYDROPYRIMIDINE SUBSTITUTED THIAZOLIDINONE DERIVATIVES

  2014cites this paper
• CHAPTER 43 n MECHANISMS OF ACTION OF ANTIEPILEPTIC DRUGS

  2014cites this paper
• Effect of N-(p-ethoxycarbonylphenylmethyl) - p-isopropoxyphenylsuccinimide on the anticonvulsant action of four classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model

  2014cites this paper
• Novel Sensitive spectrophotometric methods for determination of Retigabine in Bulk and Pharmaceutical Formulations

  2014cites this paper
• Pharmacological treatment strategies: Mechanisms of antiepileptic drugs

  2013cites this paper
• Amyloid Beta A4 Precursor Protein-binding Family B Member 1 (FE65) Interactomics Revealed Synaptic Vesicle Glycoprotein 2A (SV2A) and Sarcoplasmic/Endoplasmic Reticulum Calcium ATPase 2 (SERCA2) as New Binding Proteins in the Human Brain*

  2013cites this paper
• Kv7 potassium channel activation with ICA-105665 reduces photoparoxysmal EEG responses in patients with epilepsy

  2013cites this paper
• Research advances in basic mechanisms of seizures and antiepileptic drug action

  2013cites this paper
• Design and synthesis of some novel 2-(3-methyl-2-oxoquinoxalin-1(2H)-yl)-N-(4-(substituted)phenyl)acetamide derivatives for biological evaluation as anticonvulsant agents

  2013cites this paper
• The new KCNQ2 activator 4‐Chlor‐N‐(6‐chlor‐pyridin‐3‐yl)‐benzamid displays anticonvulsant potential

  2013cites this paper
• HCN and KV7 (M-) channels as targets for epilepsy treatment.

  2013cites this paper
• Pharmacotherapy in the Neurosurgical Intensive Care Unit

  2013cites this paper
• Research advances in basic mechanisms of seizures and antiepileptic drug action W 3 adys 3

  2013cites this paper
• Mechanisms of action of antiseizure drugs.

  2012cites this paper
• MULTIPARTICULATE MODIFIED RELEASE DRUG DELIVERY SYSTEM FOR ANTIEPILEPTIC DRUG: A REVIEW

  2012cites this paper
• RP-HPLC Method Development and Validation for the Analyisis of Telaprevir in Pharmaceutical Dosage Forms

  2012cites this paper
• The efficacy and safety of retigabine and other adjunctive treatments for refractory partial epilepsy: a systematic review and indirect comparison.

  2012cites this paper
• Kindling-associated SV2A expression in hilar GABAergic interneurons of the mouse dentate gyrus.

  2012cites this paper
• Anaesthesia and epilepsy.

  2012cites this paper
• A novel anti-epileptic agent, perampanel, selectively inhibits AMPA receptor-mediated synaptic transmission in the hippocampus.

  2012cites this paper
• Effect of 4-(4-bromophenyl)-5-(3-chlorophenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione on the anticonvulsant action of different classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model.

  2012cites this paper
• Influence of 5-(3-chlorophenyl)-4-(4-methylphenyl)-2, 4-dihydro-3H-1, 2, 4-triazole-3-thione on the anticonvulsant action of 4 classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model

  2012cites this paper
• Pregabalin antinociception and its interaction with tramadol in acute model of pain

  2012cites this paper
• No effect of 3-(N-p-isopropoxyphenylsuccinimidomethylamino)-cinnamic acid on anticonvulsant action of different classical antiepileptic drugs in mouse maximal electroshock-induced seizure model

  2012cites this paper
• From levetiracetam to brivaracetam: development of antiepileptic drugs: From levetiracetam to brivaracetam: development of antiepileptic drugs

  2011cites this paper
• Evaluation of anticonvulsants for possible use in neuropathic pain.

  2011cites this paper
• Activation of KCNQ2/3 Potassium Channels by Novel Pyrazolo[1,5-a]pyrimidin-7(4H)-One Derivatives

  2011cites this paper
• Retigabine (ezogabine) as add-on therapy for partial-onset seizures: an update for clinicians

  2011cites this paper
• Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemma

  2011cites this paper
• Novel mechanisms of drug delivery

  2010cites this paper
• Prevention or Modification of Epileptogenesis after Brain Insults: Experimental Approaches and Translational Research

  2010cites this paper